Abstract:BACKGROUND. Alterations in the function of androgen receptor (AR) and its signaling pathway may be responsible for the progression of prostate cancer. The goal of the present study was to investigate the potential roles of AR structural and functional alterations in the progression of prostate cancer, and the relationship between the structure and function of the AR. METHODS. AR gene in 58 prostate cancer samples was examined for mutations using PCR-single strand conformation polymorphism (SSCP) analysis and DNA sequencing. Effects of mutations on the structure and function of AR were investigated by androgen-binding assays and transactivation assays, respectively. RESULTS. Four novel somatic mutations (G142V, D221H, E872Q, and M8861) were identified from recurrent prostate cancer samples. None of the AR mutants differed from wild-type AR (wtAR) in their abilities to bind the synthetic androgen methyltrienolone. However, these mutated AR exhibited diverse functional characteristics as compared with wtAR. G142V and D221H showed increased responses to DHT. E872Q could be abnormally activated by 17 beta-estradiol, progesterone, and cyproterone acetate (CPA). Furthermore, E872Q and M8861 presented increased responses to DHT in the presence of coactivators TIF-2 and CBP, but not p300. On the other hand, although overexpression of corepressors N-CoR and SMRT could result in evident inhibition on DHT- or CPA-induced transactivity of wtAR and the AR mutants, N-CoR displayed stronger inhibitory effects on DHT-induced transactivity of the AR mutants (especially for E872Q and M8861) than that of wtAR. To our knowledge, this is the first characterization of enhanced inhibitory effects of corepressors on the transactivity of the AR mutants found in prostate cancer. CONCLUSIONS. The data presented here demonstrate that AR mutants found in prostate cancer had different functional alterations, which might play an important role in the progression of prostate cancer. (c) 2004 Wiley-Liss, hic.

Changes of Androgen Receptor Expression in Hormonal Dependent Prostatic Cancer and Hormonal Independent Prostatic Cancer

Expression of Androgen Receptor in Breast Cancer and Its Prognostic Significance

Expressions of the Androgen Receptor in Normal Prostate, Benign Prostatic Hyperplasia and Prostate Cancer

Expression and transcription of androgen receptor in prostate cancer cell lines with different characteristics of androgen independence

Changes of Androgen Receptor and Insulin-Like Growth Factor-1 in LNCaP Prostate Cancer Cells Treated with Sex Hormones and Flutamide.

Role of Androgen Receptor in the Pathogenesis of Human Prostate Cancer

Expression of lncRNA PCGEM1 and AR co-localization in prostate cancer and tis signiifcance

The expressions and clinical significances of AR in prostate carcinoma

Transactivity Alterations of Androgen Receptor Mutants in PC-3 Cells of Advanced Prostate Cancers

Androgen Receptor Isoforms in Human Prostatic Cancer Tissue and LNCaP Cell Line.

Androgen Receptor Functioned As a Suppressor in the Prostate Cancer Cell Line PC3 in Vitro and in Vivo.

The Change in the Expression of Cell Cycle Related Genes after the Blockage of Androgen Receptor in the Prostate Cancer Cells

[Expression and regulation of androgen receptor in the androgen-independent conversion of prostate cancer cells].

Proliferative Response of Human Prostate Cancer Cell to Hormone Inhibited by Androgen Receptor Antisense RNA

Androgen Receptor Mutants Detected in Recurrent Prostate Cancer Exhibit Diverse Functional Characteristics.

Androgen Receptor Level Controlled by a Suppressor Complex Lost in an Androgen-Independent Prostate Cancer Cell Line.

Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer

Expression Changes and Regulation of AR and IGF-1 in PC3 Prostate Cancer Cells Treated with Sexual Hormones and Flutamide

Apoptosis and Hormonal Milieu in Ductal System of Normal Prostate and Benign Prostatic Hyperplasia

Cell-by-cell quantification of the androgen receptor in benign and malignant prostate leads to a better understanding of changes linked to cancer initiation and progression

[Dynamic Change of Androgen-Receptor in Tumor and Surrounding Liver Tissue of Nude Mice Model with Transplanted Human HCC].